Intestinal clearance of H2-antagonists

Area of Science:

• Pharmacology
• Gastroenterology
• Drug Metabolism

Background:

• Cimetidine is a widely prescribed H2-antagonist.
• Understanding drug metabolism within the gastrointestinal tract is crucial for explaining absorption variability.

Purpose of the Study:

• To investigate the in situ generation of cimetidine sulfoxide in the small intestine.
• To explore the mechanisms and factors influencing lumenal metabolite formation of cimetidine and other H2-antagonists.

Main Methods:

• Jejunal and ileal perfusion studies in rats and humans.
• Co-perfusion with anionic-exchange inhibitors and methionine.
• Intravenous administration of cimetidine sulfoxide.

Main Results:

• Jejunal perfusion of cimetidine led to lumenal cimetidine sulfoxide in rats and humans.
• Anionic-exchange inhibitors and methionine affected metabolite appearance, suggesting active transport.
• Cimetidine showed greater lumenal sulfoxide formation than other H2-antagonists in rat jejunum.

Conclusions:

• The small intestine actively generates cimetidine sulfoxide.
• Intestinal transport mechanisms play a role in H2-antagonist metabolism.
• Variations in intestinal clearance of H2-antagonists may contribute to absorption variability.